Leave Your Message

Linaclotide A Versatile Peptide for Bowel Disorders and Gastrointestinal Health

  • Product Name Linaclotide
  • CAS No. 851199-59-2
  • MF C59H79N15O21S6
  • MW 1526.74
  • Appearance White power
  • Acidity coefficient (pka) 3.05±0.10(Predicted)

Detailed Description

Linaclotide, a peptide agonist of guanylate cyclase 2C, has emerged as a valuable therapeutic option for the treatment of various bowel disorders. With its unique properties and mechanisms of action, Linaclotide offers numerous benefits in managing irritable bowel syndrome (IBS) and chronic idiopathic constipation (CIC). Additionally, its potential extends to the relief of indigestion, gastritis, stomach ulcers, gastroesophageal reflux disease (GERD), and the prevention and treatment of peptic ulcers. 

Linaclotide for Bowel Disorders:
Linaclotide has proven efficacy in treating irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). By increasing fluid in the intestines and promoting the movement of food through the gut, Linaclotide helps alleviate symptoms such as bloating, abdominal pain, discomfort, straining, and feelings of incomplete bowel movements. Its ability to reduce activation of colonic sensory neurons reduces pain, while activating colonic motor neurons increases smooth muscle contraction and promotes bowel movements.

Relieving Indigestion and Gastritis:
In addition to its benefits in managing bowel disorders, Linaclotide has shown promise in relieving symptoms of indigestion and gastritis. By alleviating stomach upset, soreness, and bloating, Linaclotide capsules provide relief from unpleasant sensations. Moreover, Linaclotide can reduce gastric acid secretion and decrease the occurrence of gastric inflammation, contributing to improved digestive comfort.

Treatment of Stomach Ulcers:
Linaclotide capsules are widely used for the treatment of gastric ulcers. By inhibiting gastric acid secretion and promoting the healing process, Linaclotide aids in the repair of gastric ulcers. It also reduces the risk of ulcer recurrence and enhances the stomach's protective capacity. These properties make Linaclotide an effective therapeutic option for managing and preventing stomach ulcers.

Relief from Gastroesophageal Reflux Disease (GERD):
Linaclotide capsules have demonstrated significant efficacy in relieving symptoms associated with gastroesophageal reflux disease. Heartburn, chest tightness, and coughing caused by acid reflux can be effectively alleviated with Linaclotide. Additionally, Linaclotide aids in repairing the esophageal mucosa, reducing inflammation, and preventing further damage.

Prevention and Treatment of Peptic Ulcers:
Linaclotide capsules play a crucial role in preventing and treating peptic ulcers. By inhibiting gastric acid secretion, Linaclotide reduces the occurrence and recurrence of ulcers. Furthermore, it promotes ulcer healing and accelerates the mucosal repair process, aiding in the overall recovery of the stomach's health.

Relief from Loss of Appetite caused by Gastritis:
Linaclotide has been found to relieve loss of appetite associated with gastritis. Itsanti-inflammatory properties help reduce stomach inflammation and improve the digestive function of the stomach. As a result, Linaclotide promotes the recovery of appetite and increases food intake, addressing the issue of decreased appetite caused by gastritis.

Control of Gastric Acid Production:
One of the notable benefits of Linaclotide is its ability to control gastric acid production. By reducing gastric acid secretion, Linaclotide helps maintain a balanced acid-base environment in the stomach. This control over gastric acid production not only contributes to overall gastrointestinal health but also effectively manages gastric acid-related conditions such as gastric ulcers and gastroesophageal reflux disease.

Furthermore,tadalafil is utilized to manage pulmonary arterial hypertension(PAH)in both men and women. In this application, it helps to improve exercise capacity and delay clinical worsening of the disease.


Linaclotide, as an administered peptide agonist of guanylate cyclase 2C, offers a range of benefits for the treatment of bowel disorders and gastrointestinal health. Its ability to alleviate symptoms of irritable bowel syndrome and chronic idiopathic constipation has been well-established. Furthermore, Linaclotide shows promise in relieving indigestion, gastritis, and gastroesophageal reflux disease. It also plays a crucial role in the prevention and treatment of stomach and peptic ulcers. While Linaclotide provides significant relief and promotes gastrointestinal well-being, it is important to consult healthcare professionals for appropriate usage and dosage guidance.